1. Home
  2. EMO vs NEO Comparison

EMO vs NEO Comparison

Compare EMO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearBridge Energy Midstream Opportunity Fund Inc.

EMO

ClearBridge Energy Midstream Opportunity Fund Inc.

HOLD

Current Price

$50.25

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.26

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMO
NEO
Founded
2011
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
EMO
NEO
Price
$50.25
$8.26
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$11.14
AVG Volume (30 Days)
47.2K
1.3M
Earning Date
01-01-0001
04-28-2026
Dividend Yield
6.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.63
Revenue Next Year
N/A
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$41.54
$4.72
52 Week High
$54.90
$13.74

Technical Indicators

Market Signals
Indicator
EMO
NEO
Relative Strength Index (RSI) 36.28 46.71
Support Level $46.50 $7.33
Resistance Level $54.44 $8.89
Average True Range (ATR) 1.33 0.38
MACD -0.44 0.17
Stochastic Oscillator 8.07 76.21

Price Performance

Historical Comparison
EMO
NEO

About EMO ClearBridge Energy Midstream Opportunity Fund Inc.

ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions. The Fund considers investments in midstream entities as those entities that provide midstream services including the gathering, transporting, processing, fractionation, storing, refining, and distribution of oil, natural gas liquids and natural gas.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: